Skip to content

The interrater reliability of the classification of schouldercomplaints according to the Dutch College of General Practitioners guidelines and of clinical shouldertests

The interrater reliability of the classification of schouldercomplaints according to the Dutch College of General Practitioners guidelines and of clinical shouldertests - Interrater reliability of shouldertests

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45231
Enrollment
100
Registered
2015-10-19
Start date
2016-01-18
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

classificationalgorithm shouldercomplaint

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Aspecific and mild specific shouldercomplaints, 18 years of age or older, and agreement of the patient with the research protocol

Exclusion criteria

Exclusion criteria: • severe trauma last 3 months • signs of cervical nerve root compression • severe diseases (e.g. cancer) • presence of specific rheumatic disorders • shoulder disorders due to neurologic diseases (e.g. CVA, MS, M. Parkinson) • insulin dependant diabetes • shoulder disorders due to general internal thoracic and abdominal pathology • presence of dementia • severe psychiatric, emotional or behavioural disorders • inability to complete Dutch written questionnaires.

Design outcomes

Primary

MeasureTime frame
The inter-rater reliability between the two raters will be calculated for the individual shouldertests and for the 3 subgroups of he Dutch College of General Practitioners and the three phases of irritability. Percentages of agreement and unweighted Kappa, including its 95% CI, will serve to test inter-rater agreement and reliability.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)